Medifron DBT Co. Ltd (065650) — Capital Reinvestment Ratio
Medifron DBT Co. Ltd (065650) has a Capital Reinvestment Ratio of 0.00x as of June 2025, meaning it reinvests 0% of its operating cash flow (₩6.72 Billion) in capital expenditures (₩22.85 Million). Check Medifron DBT Co. Ltd tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Medifron DBT Co. Ltd Capital Reinvestment Ratio (2011–2014)
This chart tracks Medifron DBT Co. Ltd's Capital Reinvestment Ratio across 2 annual periods. For the full cash flow conversion analysis, see 065650 cash flow conversion.
Annual Capital Reinvestment Ratio for Medifron DBT Co. Ltd (2011–2014)
Year-by-year Capital Reinvestment Ratio for Medifron DBT Co. Ltd from 2011 to 2014. See 065650 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2014 | 38.34x | ₩701.96K | ₩26.91 Million | ▲ +129467.7% |
| 2011 | 0.03x | ₩912.56 Million | ₩27.00 Million | — |